45 results on '"Deharo, Pierre"'
Search Results
2. TCT-293 A Deep Dive Into Rotational Atherectomy-Associated Coronary Perforation From 7 High-Volume European PCI Centers
3. TCT-80 The Everolimus-Eluting Synergy Megatron Drug-Eluting Stent Platform for Aorto-Ostial and Proximal Coronary Disease: Early Outcomes From the European Synergy Megatron Implanters’ Registry
4. Active fixation lead temporary pacing in patients with right bundle block undergoing transcatheter aortic valve implantation
5. Cardiovascular outcomes in patients with cancer during a 5-year follow-up: Results from a French administrative database
6. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
7. Myocardial Revascularization Strategies in ST Elevation Myocardial Infarction Without Urgent Revascularization: Insight From a Nationwide Study
8. Advantages and disadvantages of drug challenge during electrophysiological study in patients with new left bundle branch block after transaortic valve implantation
9. UNGUIDED VERSUS GUIDED ALTERATION OF DUAL ANTIPLATELET THERAPY AFTER ACUTE CORONARY SYNDROME: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
10. Outcomes associated with pacemaker implantation following transcatheter aortic valve replacement: A nationwide cohort study
11. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry
12. Outcomes Following Aortic Stenosis Treatment (Transcatheter vs Surgical Replacement) in Women vs Men (From a Nationwide Analysis)
13. De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes
14. Prosthesis-patient mismatch is an independent predictor of congestive heart failure after transcatheter aortic valve replacement
15. Timing of Coronary Revascularization and Transcatheter Aortic Valve Replacement
16. Re-intervention for failed surgical aortic bioprosthesis: Remaining questions on long term outcomes and selection of patients
17. Valve-in-valve transcatheter aortic valve implantation after failed surgically implanted aortic bioprosthesis versus native transcatheter aortic valve implantation for aortic stenosis: Data from a nationwide analysis
18. Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
19. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI
20. Reply
21. Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation
22. Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement
23. The CHOICE Randomized Clinical Trial
24. Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome
25. Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
26. Pharmacological profile of adenosine A2A receptors in patients with lower extremity peripheral artery disease and associated coronary artery disease: A pilot study
27. Hepatitis E virus infection in heart transplant recipients, Southeastern France
28. Impact of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty on Procedural and Clinical Outcomes
29. Reply
30. Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity
31. BIVALIRUDIN VERSUS HEPARIN IN PRIMARY PCI: CLINICAL OUTCOMES AND COST ANALYSIS FROM A LARGE RETROSPECTIVE COHORT
32. The role of optical coherence tomography in decision making during the acute phase of spontaneous coronary artery dissection
33. Young Women with a Long Past of Resistant Hypertension Cured after Surgery of Severe Bilateral Ostial Renal Artery Stenosis
34. Bail-Out Alcohol Septal Ablation for Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement
35. 0010: Impact of thienopyridines on platelet CD40L biodisponibility after an acute coronary syndrome in relation with bleeding events
36. Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors
37. Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel
38. Effectiveness of switching ‘low responders’ to prasugrel to ticagrelor after acute coronary syndrome
39. Impact of new P2Y12 blockers on platelet reactivity and clinical outcomes after acute coronary syndrome: Insight from a large single center registry
40. 0230: Effectiveness of switching Prasugrel's ‘low responders’ to ticagrelor after acute coronary syndrome
41. Fixed-dose aspirin–clopidogrel combination enhances compliance to aspirin after acute coronary syndrome
42. Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting
43. Prasugrel versus ticagrelor in acute coronary syndrome: A randomized comparison
44. Effectiveness of switching ‘hyper responders’ from Prasugrel to Clopidogrel after acute coronary syndrome: The POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study
45. Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.